\-\ Texto\\:\\ \ \(0\)\
\-\ height\\:\\ 5\\&\\#39\\;3\\"\\ weight\\:\\ 232\\ lbs\ \(0\)\
\-\ bp\\:\\ 115\\/80\\ hr\\:\\ 84\\ rr\\:12\ \(0\)\
\-\ abdomen\\ tender\\ to\\ palpation\\ in\\ both\\ lower\\ quadrants\\.\\ no\\ palpable\\ masses\\ appreciated\\.\ \(0\)\
\-\ on\\ her\\ transvaginal\\ us\\,\\ bilateral\\ dermoid\\ cysts\\ was\\ suspected\\ as\\ well\\ as\\ a\\ larger\\ mass\\.\\ subsequent\\ ct\\ confirmed\\ bilateral\\ dermoid\\/teratoma\\ cysts\\ as\\ well\\ as\\ a\\ large\\ fibroid\\ causing\\ displacement\\ of\\ the\\ right\\ ovary\\.\\ \ \(0\)\
\-\ in\\ cases\\ where\\ the\\ dermoids\\ are\\ \\<6cm\\,\\ they\\ can\\ be\\ followed\\ with\\ serial\\ imaging\\.\\ however\\,\\ if\\ symptomatic\\,\\ the\\ treatment\\ is\\ bilateral\\ simple\\ cystectomy\\.\ \(0\)\
\-\ ct\\ report\\:\ \(0\)\
\-\ ovaries\\ are\\ somewhat\\ prominent\\ in\\ size\\ bilaterally\\.\\ contains\\ well\\ circumscribed\\ areas\\ of\\ fat\\ density\\ as\\ well\\ as\\ faint\\ areas\\ of\\ increased\\ density\\ suggestive\\ of\\ teratoma\\.\\ the\\ right\\ ovary\\ projects\\ at\\ midline\\ superiorly\\ on\\ the\\ pelvic\\ ct\\ apparently\\ displaced\\ by\\ pedunculated\\ uterine\\ fibroid\\.\\ \\ on\\ review\\ it\\ is\\ noted\\ that\\ the\\ right\\ ovary\\ has\\ calcium\\/bone\\ within\\ it\\ and\\ might\\ be\\ better\\ understood\\ as\\ a\\ mature\\ teratoma\\.\\ \\ whereas\\,\\ the\\ left\\ ovary\\ does\\ not\\ demonstrate\\ the\\ finding\\ of\\ calcium\\/bone\\ in\\ the\\ same\\ manner\\ and\\ might\\ better\\ be\\ described\\ as\\ a\\ dermoid\\ cyst\\.\ \(0\)\
\-\ mature\\ cystic\\ teratoma\ \(11\)\
\-\ the\\ adnexa\\ refers\\ to\\ the\\ anatomical\\ region\\ adjacent\\ to\\ the\\ uterus\\ containing\\ the\\ fallopian\\ tube\\ and\\ the\\ uterus\\ and\\ includes\\ the\\ ligaments\\,\\ vessels\\ and\\ soft\\ tissue\\ surrounding\\ these\\ structures\\.\\ a\\ variety\\ of\\ pathology\\ can\\ arise\\ here\\.\\ the\\ differential\\ for\\ an\\ adnexal\\ mass\\ includes\\:\ \(0\)\
\-\ \\?\\ physiologic\\/functional\\ cysts\\ such\\ as\\ a\\ non\\-ruptured\\ follicle\\ causing\\ follicular\\ cysts\\)\ \(0\)\
\-\ \\?\\ leiomyoma\\ \\(fibroids\\)\\ though\\ typically\\ arising\\ from\\ the\\ uterus\\ can\\ also\\ be\\ found\\ in\\ the\\ broad\\ ligament\ \(0\)\
\-\ \\?\\ polycystic\\ ovarian\\ syndrome\ \(0\)\
\-\ \\?\\ pelvic\\ inflammatory\\ disease\\ causing\\ pyosalpinx\\,\\ hydrosalpinx\\,\\ abcesses\\,\\ past\\ scarring\\ \\(\\â\\€\\œclubbing\\â\\€\\\\ of\\ the\\ fimbriae\\)\ \(0\)\
\-\ \\?\\ benign\\ ovarian\\ neoplasms\\:\\ serous\\ and\\ mucinous\\ cystadenoma\\,\\ endometrioma\\,\\ mature\\ teratoma\ \(0\)\
\-\ \\?\\ malignant\\ ovarian\\ neoplasms\ \(0\)\
\-\ \\?\\ metastatic\\ carcinoma\\ such\\ as\\ krukenberg\ \(0\)\
\-\ \\?\\ neoplasms\\ arising\\ from\\ other\\ structures\\ such\\ as\\ the\\ broad\\ ligament\\ and\\ fallopian\\ tube\ \(0\)\
\-\ 31\\ yo\\ g1p1\\ woman\\,\\ had\\ us\\ done\\ for\\ locating\\ an\\ iud\\.\\ pt\\ states\\ she\\ has\\ had\\ pain\\ in\\ her\\ abdomen\\,\\ buttocks\\ and\\ lower\\ back\\ on\\ and\\ off\\ for\\ 2\\ months\\.\\ the\\ pain\\ is\\ sore\\ and\\ cramping\\ in\\ nature\\.\\ 2\\/10\\ at\\ rest\\,\\ 6\\/10\\ when\\ exacerbated\\ with\\ touch\\ or\\ sneezing\\.\\ the\\ pain\\ does\\ not\\ radiate\\.\\ it\\ is\\ worse\\ in\\ the\\ morning\\.\\ she\\ also\\ noticed\\ increase\\ in\\ menstrual\\ flow\\.\\ pt\\ attributed\\ these\\ symptoms\\ to\\ her\\ iud\\,\\ and\\ decided\\ to\\ change\\ types\\.\\ the\\ iud\\ was\\ unable\\ to\\ be\\ found\\ visually\\ on\\ physical\\ examination\\ in\\ the\\ office\\,\\ which\\ led\\ to\\ the\\ us\\.\\ subsequent\\ ct\\ was\\ done\\ to\\ confirm\\ us\\ findings\\.\\ \ \(0\)\
\-\ of\\ note\\,\\ approximately\\ 6\\ months\\ prior\\ to\\ these\\ images\\,\\ the\\ patient\\ was\\ hospitalized\\ for\\ acute\\ bleeding\\ and\\ a\\ rash\\.\\ she\\ was\\ diagnosed\\ with\\ idiopathic\\ thrombocytopenia\\.\\ she\\ was\\ transfused\\ and\\ stabalized\\,\\ and\\ discharged\\ after\\ a\\ 5\\ day\\ stay\\.\\ she\\ has\\ subsequently\\ followed\\ up\\ with\\ hematology\\ and\\ rheumatology\\,\\ and\\ was\\ given\\ a\\ course\\ of\\ prednisone\\ and\\ hydrochloroquine\\.\\ her\\ repeat\\ serial\\ cbcs\\ have\\ been\\ stable\\ and\\ she\\ has\\ remained\\ asymptomatic\\.\ \(0\)\
\-\ case\\ contributors\\:peter\\ tang\\,\\ msiii\\;\\ june\\ koshy\\,\\ md\\;\\ randall\\ loftus\\,\\ md\\;\\ joanna\\ garvey\\,\\ dc\\;\\ robert\\ lutnick\\,\\ md\\;\\ ashley\\ newbury\\,\\ dc\\;\\ scott\\ croce\\,\\ dc\\;\\ krishnan\\ kartha\\,\\ md\\;\\ joseph\\ serghany\\,\\ md\\;\\ charles\\ tirone\\ md\\,\\ vaseem\\ iqbal\\ md\\;\\ geoffrey\\ gerow\\,\\ dc\\.\\ \\ \\ \ \(0\)\
\-\ mature\\ cystic\\ teratomas\\ are\\ commonly\\ asymptomatic\\ and\\ are\\ only\\ found\\ on\\ incidental\\ imaging\\.\\ in\\ this\\ patient\\,\\ \\ it\\ is\\ likely\\ her\\ abdominal\\ pain\\ is\\ due\\ to\\ the\\ mass\\ effect\\ of\\ the\\ large\\ fibroid\\ displacing\\ her\\ ovaries\\ and\\ other\\ pelvic\\ structures\\.\\ any\\ pain\\ due\\ to\\ the\\ stretching\\ of\\ the\\ ligaments\\ would\\ be\\ exacerbated\\ by\\ jerky\\ movements\\ sudden\\ increase\\ in\\ pressure\\ such\\ as\\ sneezing\\.\\ the\\ patient\\ has\\ decided\\ to\\ undergo\\ attempted\\ laparoscopic\\ resection\\.\ \(0\)\
\-\ approximately\\ 6\\ months\\ prior\\ to\\ the\\ patient\\&\\#39\\;s\\ incidental\\ finding\\ of\\ her\\ mature\\ teratoma\\,\\ she\\ was\\ urgently\\ hospitalized\\ for\\ an\\ acute\\ onset\\ of\\ bleeding\\ and\\ rash\\.\\ she\\ initially\\ presented\\ with\\ epistaxis\\ and\\ also\\ a\\ rash\\ after\\ scratching\\ her\\ arm\\.\\ the\\ rash\\ was\\ described\\ as\\ flat\\ round\\ dots\\ and\\ very\\ dark\\.\\ \\ the\\ rash\\ spread\\ to\\ involve\\ her\\ lips\\,\\ fingertip\\ and\\ back\\ of\\ mouth\\.\\ as\\ her\\ rash\\ got\\ worse\\,\\ she\\ went\\ to\\ the\\ er\\ where\\ her\\ cbc\\ showed\\ a\\ platelet\\ count\\ of\\ 6\\,000\\.\\ subsequent\\ work\\ up\\ was\\ negative\\ and\\ she\\ was\\ diagnosed\\ with\\ idiopathic\\ thrombocytopenic\\ purpura\\ \\(itp\\)\\.\\ \\ itp\\ is\\ a\\ condition\\ where\\ there\\ is\\ immunologic\\ destruction\\ of\\ platetes\\,\\ due\\ to\\ the\\ formation\\ of\\ igg\\ to\\ various\\ antigens\\,\\ such\\ as\\ glycoprotein\\ iib\\/iiia\\.\\ pt\\ was\\ transfused\\ and\\ after\\ three\\ days\\ her\\ platelets\\ were\\ elevated\\ to\\ 114\\,000\\.\\ she\\ has\\ since\\ been\\ given\\ a\\ course\\ of\\ steroids\\ and\\ hydrochloroquine\\.\\ subsequent\\ hematology\\ and\\ rheumatology\\ followup\\ has\\ not\\ suggested\\ any\\ chronic\\ disease\\ contributing\\ to\\ her\\ episode\\ of\\ itp\\.\\ subsequent\\ cbcs\\ have\\ been\\ stable\\,\\ and\\ the\\ patient\\ remains\\ asymptomatic\\.\ \(0\)\
\-\ although\\ itp\\ has\\ never\\ been\\ associated\\ with\\ mature\\ cystic\\ teratomas\\ specifically\\,\\ there\\ have\\ been\\ case\\ reports\\ of\\ paraneoplastic\\ itp\\ associated\\ with\\ ovarian\\ cancer\\,\\ and\\ other\\ malignancies\\ such\\ as\\ breast\\,\\ and\\ lung\\ \\[1\\]\\.\\ it\\ has\\ been\\ suggested\\ that\\ malignancy\\ associated\\ itp\\ is\\ not\\ an\\ uncommon\\ occurrence\\ and\\ a\\ separate\\ classification\\ of\\ this\\ \\"secondary\\ itp\\"\\ should\\ be\\ considered\\.\\ because\\ malignant\\ transformation\\ is\\ unlikely\\ in\\ classic\\ mature\\ cystic\\ teratomas\\,\\ and\\ lack\\ of\\ research\\ in\\ this\\ area\\,\\ it\\ is\\ not\\ clear\\ that\\ in\\ this\\ patient\\ her\\ itp\\ is\\ of\\ an\\ analogous\\ paraneoplastic\\ etiology\\.\\ \ \(0\)\
\-\ however\\,\\ there\\ have\\ been\\ two\\ reported\\ autoimmune\\ paraneoplastic\\ syndromes\\ associated\\ with\\ mature\\ cystic\\ teratomas\\:\\ autoimmune\\ hemolytic\\ anemia\\ \\(aiha\\)\\,\\ and\\ anti\\-nmda\\ receptor\\ encephalitis\\ \\[2\\-3\\]\\.\\ aiha\\ is\\ similar\\ to\\ itp\\ in\\ that\\,\\ the\\ mechanism\\ involves\\ igg\\ \\(or\\ igm\\,\\ iga\\)\\ formation\\ vs\\ rbc\\ antigens\\ such\\ as\\ rh\\ factor\\.\\ interestingly\\,\\ in\\ the\\ reported\\ cases\\ of\\ aiha\\,\\ a\\ portion\\ of\\ patients\\ were\\ refractory\\ to\\ steroid\\ treatment\\.\\ only\\ the\\ resection\\ of\\ the\\ cysts\\ led\\ to\\ symptom\\ resolution\\,\\ thus\\ supporting\\ a\\ causal\\ relationship\\.\\ proposed\\ theories\\ of\\ the\\ pathophysiology\\ include\\ the\\ creation\\ of\\ antibodies\\ or\\ the\\ modification\\ of\\ red\\ blood\\ cells\\ by\\ the\\ teratoma\\ itself\\.\\ \ \(0\)\
\-\ therefore\\,\\ because\\ mature\\ teratomas\\ have\\ been\\ associated\\ with\\ aiha\\,\\ and\\ itp\\ is\\ of\\ a\\ similar\\ pathophysiologic\\ process\\,\\ i\\ suggest\\ that\\ it\\ is\\ not\\ unreasonable\\ to\\ consider\\ this\\ patient\\&\\#39\\;s\\ mature\\ teratoma\\ a\\ possible\\ etiology\\ of\\ her\\ episode\\ of\\ itp\\.\\ further\\ research\\ to\\ elucidate\\ the\\ relationship\\ between\\ itp\\ and\\ neoplasms\\ may\\ be\\ of\\ clinical\\ benefit\\ to\\ patients\\,\\ in\\ terms\\ of\\ treatment\\ and\\ neoplasm\\ detection\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ krauth\\ mt\\,\\ puthenparambil\\ j\\,\\ lechner\\ k\\.\\ paraneoplastic\\ autoimmune\\ thrombocytopenia\\ in\\ solid\\ tumors\\.\\ crit\\ rev\\ oncol\\ hematol\\.\\ 2012\\ jan\\;81\\(1\\)\\:75\\-81\\.\\ doi\\:\\ 10\\.1016\\/j\\.critrevonc\\.2011\\.02\\.004\\.\\ epub\\ 2011\\ apr\\ 22\\.\\ review\\.\ \(0\)\
\-\ 2\\.\\ buchwalter\\ cl\\,\\ miller\\ d\\,\\ jenison\\ el\\.\\ hemolytic\\ anemia\\ and\\ benign\\ pelvic\\ tumors\\.\\ a\\ case\\ report\\.\\ j\\ reprod\\ med\\.\\ 2001\\ apr\\;46\\(4\\)\\:401\\-4\\.\ \(0\)\
\-\ 3\\.\\ lancaster\\,\\ eric\\ \\(07\\/12\\/2011\\)\\.\\ \\"encephalitis\\ and\\ antibodies\\ to\\ synaptic\\ and\\ neuronal\\ cell\\ surface\\ proteins\\"\\.\\ neurology\\ \\(0028\\-3878\\)\\,\\ 77\\ \\(2\\)\\,\\ p\\.\\ 179\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ itp\\:\\ 0\\.07717217333402901\ \(0\)\
\-\ mature\\:\\ 0\\.0407914234191358\ \(0\)\
\-\ her\\:\\ 0\\.030515577891745076\ \(0\)\
\-\ aiha\\:\\ 0\\.02791929825484243\ \(0\)\
\-\ rash\\:\\ 0\\.024724943046661632\ \(0\)\
\-\ \\;\\:\\ 0\\.024054883473308714\ \(0\)\
\-\ teratomas\\:\\ 0\\.02345663763289918\ \(0\)\
\-\ md\\:\\ 0\\.023390965967397752\ \(0\)\
\-\ teratoma\\:\\ 0\\.022143038803270173\ \(0\)\
\-\ \\?\\:\\ 0\\.021123543946948577\ \(0\)\
\-\ she\\:\\ 0\\.020892040820265953\ \(0\)\
\-\ paraneoplastic\\:\\ 0\\.019561238620273126\ \(0\)\
\-\ as\\:\\ 0\\.017398113697704016\ \(0\)\
\-\ iud\\:\\ 0\\.01631735932282942\ \(0\)\
\-\ such\\:\\ 0\\.01480548656285508\ \(0\)\
\-\ been\\:\\ 0\\.014725541659312691\ \(0\)\
\-\ ovary\\:\\ 0\\.014602773727871837\ \(0\)\
\-\ dc\\:\\ 0\\.01433114483869551\ \(0\)\
\-\ calcium\\/bone\\:\\ 0\\.013959649127421215\ \(0\)\
\-\ hydrochloroquine\\:\\ 0\\.013959649127421215\ \(0\)\
\-\ cbcs\\:\\ 0\\.013959649127421215\ \(0\)\
\-\ neoplasms\\:\\ 0\\.013775487902808914\ \(0\)\
\-\ cysts\\:\\ 0\\.01325201220439971\ \(0\)\
\-\ subsequent\\:\\ 0\\.01316936143234288\ \(0\)\
\-\ \\,\\:\\ 0\\.013074674581595036\ \(0\)\
\-\ autoimmune\\:\\ 0\\.012941146303990556\ \(0\)\
\-\ sneezing\\:\\ 0\\.012862028889004834\ \(0\)\
\-\ fibroid\\:\\ 0\\.012563320426010301\ \(0\)\
\-\ ovarian\\:\\ 0\\.012383986209115024\ \(0\)\
\-\ hematology\\:\\ 0\\.011764408650588452\ \(0\)\
\-\ has\\:\\ 0\\.011434916654353524\ \(0\)\
\-\ antigens\\:\\ 0\\.011411053858325254\ \(0\)\
\-\ us\\:\\ 0\\.01135205006211215\ \(0\)\
\-\ pelvic\\:\\ 0\\.01110768242776023\ \(0\)\
\-\ transfused\\:\\ 0\\.010878239548552944\ \(0\)\
\-\ it\\:\\ 0\\.010646032218314424\ \(0\)\
\-\ thrombocytopenia\\:\\ 0\\.010313433619908871\ \(0\)\
\-\ hemolytic\\:\\ 0\\.010024721732665871\ \(0\)\
\-\ rheumatology\\:\\ 0\\.00989797160174974\ \(0\)\
\-\ apr\\:\\ 0\\.00989797160174974\ \(0\)\
\-\ \\:\\:\\ 0\\.00984404036096383\ \(0\)\
\-\ antibodies\\:\\ 0\\.009780619310136563\ \(0\)\
\-\ cystic\\:\\ 0\\.009757057431717174\ \(0\)\
\-\ uterus\\:\\ 0\\.009567759337730292\ \(0\)\
\-\ 39\\:\\ 0\\.00943309106296415\ \(0\)\
\-\ was\\:\\ 0\\.009389810187303439\ \(0\)\
\-\ hospitalized\\:\\ 0\\.009297037917339759\ \(0\)\
\-\ igg\\:\\ 0\\.009297037917339759\ \(0\)\
\-\ research\\:\\ 0\\.009138552630630363\ \(0\)\
\-\ exacerbated\\:\\ 0\\.008800351363333358\ \(0\)\
\-\ decided\\:\\ 0\\.008800351363333358\ \(0\)\
\-\ to\\:\\ 0\\.008791584180140652\ \(0\)\
\-\ causing\\:\\ 0\\.008768537873071826\ \(0\)\
\-\ ovaries\\:\\ 0\\.008422820051464793\ \(0\)\
\-\ be\\:\\ 0\\.008346835935670175\ \(0\)\
\-\ where\\:\\ 0\\.00828418587928009\ \(0\)\
\-\ led\\:\\ 0\\.008199417678923376\ \(0\)\
\-\ relationship\\:\\ 0\\.00804093239221398\ \(0\)\
\-\ associated\\:\\ 0\\.007982828827821463\ \(0\)\
\-\ fallopian\\:\\ 0\\.00796726649255461\ \(0\)\
\-\ \\#\\:\\ 0\\.007961250876344153\ \(0\)\
\-\ structures\\:\\ 0\\.007814882386780795\ \(0\)\
\-\ might\\:\\ 0\\.007672567712453486\ \(0\)\
\-\ ligaments\\:\\ 0\\.0075573509994171775\ \(0\)\
\-\ encephalitis\\:\\ 0\\.0075573509994171775\ \(0\)\
\-\ pt\\:\\ 0\\.007546707255659745\ \(0\)\
\-\ have\\:\\ 0\\.007325566422664654\ \(0\)\
\-\ \\&\\:\\ 0\\.007129187392259933\ \(0\)\
\-\ \\]\\:\\ 0\\.007081097390519104\ \(0\)\
\-\ \\[\\:\\ 0\\.007060664445410778\ \(0\)\
\-\ broad\\:\\ 0\\.007020572904659725\ \(0\)\
\-\ better\\:\\ 0\\.006981471380367767\ \(0\)\
\-\ rr\\:12\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ dermoid\\/teratoma\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ physiologic\\/functional\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ non\\-ruptured\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ locating\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ stabalized\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ koshy\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ jerky\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ 6\\,000\\.\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ platetes\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ iib\\/iiia\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ 114\\,000\\.\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ anti\\-nmda\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ krauth\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ puthenparambil\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ lechner\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ \\:75\\-81\\.\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ 10\\.1016\\/j\\.critrevonc\\.2011\\.02\\.004\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ buchwalter\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ jenison\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ reprod\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ \\:401\\-4\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ lancaster\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ 07\\/12\\/2011\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ synaptic\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ 0028\\-3878\\:\\ 0\\.006979824563710608\ \(0\)\
\-\ suggested\\:\\ 0\\.006887743951404457\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.006861264603316122\ \(0\)\
\-\ serial\\:\\ 0\\.006748442648243797\ \(0\)\
\-\ anemia\\:\\ 0\\.006731861017416726\ \(0\)\
\-\ episode\\:\\ 0\\.006699209731268291\ \(0\)\
\-\ is\\:\\ 0\\.006678037748037121\ \(0\)\
\-\ 232\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ 115\\/80\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ abcesses\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ fimbriae\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ krukenberg\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ 2\\/10\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ tang\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ scratching\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ fingertip\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ analogous\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ crit\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ hematol\\:\\ 0\\.006431014444502417\ \(0\)\
\-\ found\\:\\ 0\\.006396735426252048\ \(0\)\
\-\ in\\:\\ 0\\.006339309083661792\ \(0\)\
\-\ ligament\\:\\ 0\\.006215628338471488\ \(0\)\
\-\ \\)\\:\\ 0\\.006214500881430211\ \(0\)\
\-\ dermoid\\:\\ 0\\.0061687054602349535\ \(0\)\
\-\ idiopathic\\:\\ 0\\.0061687054602349535\ \(0\)\
\-\ well\\:\\ 0\\.00612218829127047\ \(0\)\
\-\ j\\:\\ 0\\.006111941989493646\ \(0\)\
\-\ urgently\\:\\ 0\\.006109981104749317\ \(0\)\
\-\ dots\\:\\ 0\\.006109981104749317\ \(0\)\
\-\ glycoprotein\\:\\ 0\\.006109981104749317\ \(0\)\
\-\ creation\\:\\ 0\\.006109981104749317\ \(0\)\
\-\ pathophysiologic\\:\\ 0\\.006109981104749317\ \(0\)\
\-\ unreasonable\\:\\ 0\\.006109981104749317\ \(0\)\
\-\ elucidate\\:\\ 0\\.006109981104749317\ \(0\)\
\-\ el\\:\\ 0\\.006109981104749317\ \(0\)\
\-\ report\\:\\ 0\\.006057143051762093\ \(0\)\
\-\ worse\\:\\ 0\\.0059937933532447545\ \(0\)\
\-\ a\\:\\ 0\\.005966267802496773\ \(0\)\
\-\ follicle\\:\\ 0\\.005882204325294226\ \(0\)\
\-\ causal\\:\\ 0\\.005882204325294226\ \(0\)\
\-\ 179\\:\\ 0\\.005882204325294226\ \(0\)\
\-\ bleeding\\:\\ 0\\.005874224782368832\ \(0\)\
\-\ not\\:\\ 0\\.005866121956018696\ \(0\)\
\-\ review\\:\\ 0\\.0058646565884559855\ \(0\)\
\-\ that\\:\\ 0\\.005843154111475943\ \(0\)\
\-\ described\\:\\ 0\\.005763054143139618\ \(0\)\
\-\ etiology\\:\\ 0\\.005727666496754826\ \(0\)\
\-\ \\(\\:\\ 0\\.005719411925921302\ \(0\)\
\-\ immunologic\\:\\ 0\\.005705526929162627\ \(0\)\
\-\ eric\\:\\ 0\\.005705526929162627\ \(0\)\
\-\ tube\\:\\ 0\\.005701635259473496\ \(0\)\
\-\ and\\:\\ 0\\.005700997806246031\ \(0\)\
\-\ increase\\:\\ 0\\.005676025031056075\ \(0\)\
\-\ done\\:\\ 0\\.0056096894147311975\ \(0\)\
\-\ arising\\:\\ 0\\.005601589492851909\ \(0\)\
\-\ formation\\:\\ 0\\.005585512895125832\ \(0\)\
\-\ stable\\:\\ 0\\.005577535390723683\ \(0\)\
\-\ visually\\:\\ 0\\.005561170985541126\ \(0\)\
\-\ peter\\:\\ 0\\.005561170985541126\ \(0\)\
\-\ lips\\:\\ 0\\.005561170985541126\ \(0\)\
\-\ thrombocytopenic\\:\\ 0\\.005561170985541126\ \(0\)\
\-\ months\\:\\ 0\\.005543803550332701\ \(0\)\
\-\ includes\\:\\ 0\\.005455075844558726\ \(0\)\
\-\ cystectomy\\:\\ 0\\.005439119774276472\ \(0\)\
\-\ pyosalpinx\\:\\ 0\\.005439119774276472\ \(0\)\
\-\ rh\\:\\ 0\\.005439119774276472\ \(0\)\
\-\ theories\\:\\ 0\\.005439119774276472\ \(0\)\
\-\ epub\\:\\ 0\\.005439119774276472\ \(0\)\
\-\ proteins\\:\\ 0\\.005439119774276472\ \(0\)\
\-\ due\\:\\ 0\\.005416335280173016\ \(0\)\
\-\ dermoids\\:\\ 0\\.0053333942060860345\ \(0\)\
\-\ got\\:\\ 0\\.0053333942060860345\ \(0\)\
\-\ mt\\:\\ 0\\.0053333942060860345\ \(0\)\
\-\ rev\\:\\ 0\\.0053333942060860345\ \(0\)\
\-\ doi\\:\\ 0\\.0053333942060860345\ \(0\)\
\-\ similar\\:\\ 0\\.0053075005842294345\ \(0\)\
\-\ these\\:\\ 0\\.005282291429828599\ \(0\)\
\-\ g1p1\\:\\ 0\\.005240137645788027\ \(0\)\
\-\ iga\\:\\ 0\\.005240137645788027\ \(0\)\
\-\ oncol\\:\\ 0\\.005240137645788027\ \(0\)\
\-\ 6cm\\:\\ 0\\.0051567168099544355\ \(0\)\
\-\ purpura\\:\\ 0\\.0051567168099544355\ \(0\)\
\-\ 22\\.\\:\\ 0\\.0051567168099544355\ \(0\)\
\-\ the\\:\\ 0\\.005144668551916399\ \(0\)\
\-\ incidental\\:\\ 0\\.005123972443357523\ \(0\)\
\-\ course\\:\\ 0\\.005106146387103153\ \(0\)\
\-\ tumors\\:\\ 0\\.005082686235424388\ \(0\)\
\-\ newbury\\:\\ 0\\.005081253484693688\ \(0\)\
\-\ miller\\:\\ 0\\.005081253484693688\ \(0\)\
\-\ cramping\\:\\ 0\\.0050123608663329355\ \(0\)\
\-\ ashley\\:\\ 0\\.0050123608663329355\ \(0\)\
\-\ receptor\\:\\ 0\\.0050123608663329355\ \(0\)\
\-\ diagnosed\\:\\ 0\\.004975764302129858\ \(0\)\
\-\ radiate\\:\\ 0\\.00494898580087487\ \(0\)\
\-\ igm\\:\\ 0\\.00494898580087487\ \(0\)\
\-\ supporting\\:\\ 0\\.00494898580087487\ \(0\)\
\-\ reported\\:\\ 0\\.004932818449051166\ \(0\)\
\-\ bilateral\\:\\ 0\\.004925932848727895\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.0048925166317868\ \(0\)\
\-\ malignant\\:\\ 0\\.0048910066134272385\ \(0\)\
\-\ understood\\:\\ 0\\.0048903096550682815\ \(0\)\
\-\ epistaxis\\:\\ 0\\.0048903096550682815\ \(0\)\
\-\ transvaginal\\:\\ 0\\.0048356834702013365\ \(0\)\
\-\ 6\\/10\\:\\ 0\\.0048356834702013365\ \(0\)\
\-\ platelet\\:\\ 0\\.0048356834702013365\ \(0\)\
\-\ modification\\:\\ 0\\.0048356834702013365\ \(0\)\
\-\ stretching\\:\\ 0\\.004784584086877843\ \(0\)\
\-\ jan\\:\\ 0\\.004784584086877843\ \(0\)\
\-\ neuronal\\:\\ 0\\.004784584086877843\ \(0\)\
\-\ patient\\:\\ 0\\.0047475403930441135\ \(0\)\
\-\ k\\.\\:\\ 0\\.004736583594544958\ \(0\)\
\-\ because\\:\\ 0\\.0047339957507300835\ \(0\)\
\-\ refers\\:\\ 0\\.0046913275265798365\ \(0\)\
\-\ other\\:\\ 0\\.004678476362713655\ \(0\)\
\-\ an\\:\\ 0\\.004678008172148574\ \(0\)\
\-\ benign\\:\\ 0\\.004669913486988442\ \(0\)\
\-\ msiii\\:\\ 0\\.0046485189586698795\ \(0\)\
\-\ given\\:\\ 0\\.004638819307230946\ \(0\)\
\-\ does\\:\\ 0\\.0046169771502517915\ \(0\)\
\-\ projects\\:\\ 0\\.004607906690746244\ \(0\)\
\-\ manner\\:\\ 0\\.004607906690746244\ \(0\)\
\-\ buttocks\\:\\ 0\\.004607906690746244\ \(0\)\
\-\ can\\:\\ 0\\.004603853568810142\ \(0\)\
\-\ quadrants\\:\\ 0\\.004569276315315182\ \(0\)\
\-\ cl\\:\\ 0\\.004569276315315182\ \(0\)\
\-\ areas\\:\\ 0\\.004553202171411032\ \(0\)\
\-\ followed\\:\\ 0\\.004536620540583961\ \(0\)\
\-\ contributing\\:\\ 0\\.004532443365485497\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.004532443365485497\ \(0\)\
\-\ cases\\:\\ 0\\.004508014036391342\ \(0\)\
\-\ hydrosalpinx\\:\\ 0\\.0044972479873613205\ \(0\)\
\-\ serous\\:\\ 0\\.0044972479873613205\ \(0\)\
\-\ displacing\\:\\ 0\\.0044972479873613205\ \(0\)\
\-\ interestingly\\:\\ 0\\.0044972479873613205\ \(0\)\
\-\ back\\:\\ 0\\.004464079707596955\ \(0\)\
\-\ follicular\\:\\ 0\\.004463550747124744\ \(0\)\
\-\ menstrual\\:\\ 0\\.004463550747124744\ \(0\)\
\-\ proposed\\:\\ 0\\.004463550747124744\ \(0\)\
\-\ density\\:\\ 0\\.004452306186634931\ \(0\)\
\-\ case\\:\\ 0\\.00444062810657309\ \(0\)\
\-\ apparently\\:\\ 0\\.004431229294614645\ \(0\)\
\-\ june\\:\\ 0\\.004431229294614645\ \(0\)\
\-\ occurrence\\:\\ 0\\.004431229294614645\ \(0\)\
\-\ sore\\:\\ 0\\.004400175681666679\ \(0\)\
\-\ platelets\\:\\ 0\\.004400175681666679\ \(0\)\
\-\ 81\\:\\ 0\\.004400175681666679\ \(0\)\
\-\ terms\\:\\ 0\\.0043702941868267375\ \(0\)\
\-\ finding\\:\\ 0\\.00436114252579332\ \(0\)\
\-\ fibroids\\:\\ 0\\.00434149953586009\ \(0\)\
\-\ malignancies\\:\\ 0\\.004313715434663518\ \(0\)\
\-\ 2012\\:\\ 0\\.004313715434663518\ \(0\)\
\-\ faint\\:\\ 0\\.004286873350993145\ \(0\)\
\-\ pedunculated\\:\\ 0\\.004286873350993145\ \(0\)\
\-\ adnexa\\:\\ 0\\.004286873350993145\ \(0\)\
\-\ attributed\\:\\ 0\\.004286873350993145\ \(0\)\
\-\ office\\:\\ 0\\.004286873350993145\ \(0\)\
\-\ stay\\:\\ 0\\.004286873350993145\ \(0\)\
\-\ 2011\\:\\ 0\\.004286873350993145\ \(0\)\
\-\ any\\:\\ 0\\.00426102143004322\ \(0\)\
\-\ 84\\:\\ 0\\.004260911496026407\ \(0\)\
\-\ anatomical\\:\\ 0\\.004260911496026407\ \(0\)\
\-\ resection\\:\\ 0\\.004219977285067646\ \(0\)\
\-\ laparoscopic\\:\\ 0\\.004211410025732397\ \(0\)\
\-\ after\\:\\ 0\\.004199527797171502\ \(0\)\
\-\ clubbing\\:\\ 0\\.004187773475336767\ \(0\)\
\-\ refractory\\:\\ 0\\.004187773475336767\ \(0\)\
\-\ approximately\\:\\ 0\\.004186568213072973\ \(0\)\
\-\ endometrioma\\:\\ 0\\.004164822139728491\ \(0\)\
\-\ pain\\:\\ 0\\.0041314654296545315\ \(0\)\
\-\ neurology\\:\\ 0\\.004120823841110272\ \(0\)\
\-\ 77\\:\\ 0\\.004120823841110272\ \(0\)\
\-\ treatment\\:\\ 0\\.0041083538232800166\ \(0\)\
\-\ only\\:\\ 0\\.004068743718899343\ \(0\)\
\-\ mucinous\\:\\ 0\\.004059096571538054\ \(0\)\
\-\ 6\\:\\ 0\\.004041362092438439\ \(0\)\
\-\ benefit\\:\\ 0\\.0040395458093920745\ \(0\)\
\-\ whereas\\:\\ 0\\.00402046619610699\ \(0\)\
\-\ abdomen\\:\\ 0\\.004008526148686771\ \(0\)\
\-\ variety\\:\\ 0\\.004001835556827344\ \(0\)\
\-\ polycystic\\:\\ 0\\.004001835556827344\ \(0\)\
\-\ prednisone\\:\\ 0\\.004001835556827344\ \(0\)\
\-\ also\\:\\ 0\\.004001471718931476\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.003983633246277305\ \(0\)\
\-\ never\\:\\ 0\\.003983633246277305\ \(0\)\
\-\ flat\\:\\ 0\\.003965840011240046\ \(0\)\
\-\ 5\\:\\ 0\\.003959082220814193\ \(0\)\
\-\ scarring\\:\\ 0\\.00394843786815313\ \(0\)\
\-\ lutnick\\:\\ 0\\.00394843786815313\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.003931409993868915\ \(0\)\
\-\ detection\\:\\ 0\\.003931409993868915\ \(0\)\
\-\ lbs\\:\\ 0\\.003898414984842337\ \(0\)\
\-\ croce\\:\\ 0\\.003898414984842337\ \(0\)\
\-\ rbc\\:\\ 0\\.003898414984842337\ \(0\)\
\-\ iqbal\\:\\ 0\\.0038824191754064544\ \(0\)\
\-\ med\\:\\ 0\\.0038824191754064544\ \(0\)\
\-\ s\\:\\ 0\\.0038808672480040965\ \(0\)\
\-\ robert\\:\\ 0\\.0038667401355836676\ \(0\)\
\-\ scott\\:\\ 0\\.0038667401355836676\ \(0\)\
\-\ tirone\\:\\ 0\\.0038667401355836676\ \(0\)\
\-\ classification\\:\\ 0\\.0038667401355836676\ \(0\)\
\-\ syndromes\\:\\ 0\\.0038667401355836676\ \(0\)\
\-\ transformation\\:\\ 0\\.003836283856226743\ \(0\)\
\-\ symptom\\:\\ 0\\.003836283856226743\ \(0\)\
\-\ charles\\:\\ 0\\.003821484067618546\ \(0\)\
\-\ vaseem\\:\\ 0\\.003821484067618546\ \(0\)\
\-\ mouth\\:\\ 0\\.0038069558501457063\ \(0\)\
\-\ itself\\:\\ 0\\.0038069558501457063\ \(0\)\
\-\ this\\:\\ 0\\.003804977091504881\ \(0\)\
\-\ specifically\\:\\ 0\\.003792689416651899\ \(0\)\
\-\ ct\\:\\ 0\\.003785601435920959\ \(0\)\
\-\ attempted\\:\\ 0\\.0037786754997085887\ \(0\)\
\-\ however\\:\\ 0\\.0037678037301616314\ \(0\)\
\-\ superiorly\\:\\ 0\\.003764905315455328\ \(0\)\
\-\ separate\\:\\ 0\\.0037513705305310995\ \(0\)\
\-\ adnexal\\:\\ 0\\.0037380632317849547\ \(0\)\
\-\ various\\:\\ 0\\.0037380632317849547\ \(0\)\
\-\ morning\\:\\ 0\\.0036994328563538918\ \(0\)\
\-\ noticed\\:\\ 0\\.0036994328563538918\ \(0\)\
\-\ dark\\:\\ 0\\.0036994328563538918\ \(0\)\
\-\ are\\:\\ 0\\.0036892284165624756\ \(0\)\
\-\ remained\\:\\ 0\\.0036869638484614614\ \(0\)\
\-\ randall\\:\\ 0\\.0036746881663268886\ \(0\)\
\-\ loftus\\:\\ 0\\.0036746881663268886\ \(0\)\
\-\ movements\\:\\ 0\\.0036746881663268886\ \(0\)\
\-\ consider\\:\\ 0\\.0036746881663268886\ \(0\)\
\-\ touch\\:\\ 0\\.0036506934319679592\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.0036506934319679592\ \(0\)\
\-\ up\\:\\ 0\\.003638712828272721\ \(0\)\
\-\ contains\\:\\ 0\\.0036160120205203\ \(0\)\
\-\ contributors\\:\\ 0\\.0036160120205203\ \(0\)\
\-\ went\\:\\ 0\\.003604781113955014\ \(0\)\
\-\ 2001\\:\\ 0\\.0035937072881634543\ \(0\)\
\-\ krishnan\\:\\ 0\\.0035827862096738773\ \(0\)\
\-\ kartha\\:\\ 0\\.0035827862096738773\ \(0\)\
\-\ 46\\:\\ 0\\.0035827862096738773\ \(0\)\
\-\ steroid\\:\\ 0\\.003572013721902081\ \(0\)\
\-\ height\\:\\ 0\\.0035613858356533554\ \(0\)\
\-\ 31\\:\\ 0\\.0035508987202534973\ \(0\)\
\-\ joanna\\:\\ 0\\.0035508987202534973\ \(0\)\
\-\ garvey\\:\\ 0\\.0035508987202534973\ \(0\)\
\-\ serghany\\:\\ 0\\.0035508987202534973\ \(0\)\
\-\ geoffrey\\:\\ 0\\.003540548695259552\ \(0\)\
\-\ gerow\\:\\ 0\\.003540548695259552\ \(0\)\
\-\ here\\:\\ 0\\.003530332222705389\ \(0\)\
\-\ red\\:\\ 0\\.003530332222705389\ \(0\)\
\-\ remains\\:\\ 0\\.0035202458998412323\ \(0\)\
\-\ patients\\:\\ 0\\.0035020975445226063\ \(0\)\
\-\ joseph\\:\\ 0\\.0035004507278654467\ \(0\)\
\-\ mechanism\\:\\ 0\\.0034811384134361837\ \(0\)\
\-\ prior\\:\\ 0\\.0034744461950947953\ \(0\)\
\-\ uterine\\:\\ 0\\.0034716560768987994\ \(0\)\
\-\ p\\:\\ 0\\.0034716560768987994\ \(0\)\
\-\ types\\:\\ 0\\.003453025437619153\ \(0\)\
\-\ factor\\:\\ 0\\.003453025437619153\ \(0\)\
\-\ confirm\\:\\ 0\\.0034438719757022285\ \(0\)\
\-\ on\\:\\ 0\\.003438912172757378\ \(0\)\
\-\ containing\\:\\ 0\\.0034348231270691144\ \(0\)\
\-\ undergo\\:\\ 0\\.0034348231270691144\ \(0\)\
\-\ by\\:\\ 0\\.0033797408628144293\ \(0\)\
\-\ d\\:\\ 0\\.0033742213241218983\ \(0\)\
\-\ thus\\:\\ 0\\.003365930508708363\ \(0\)\
\-\ arise\\:\\ 0\\.0033496048656341455\ \(0\)\
\-\ destruction\\:\\ 0\\.0033415665667711073\ \(0\)\
\-\ acute\\:\\ 0\\.0033410599035732305\ \(0\)\
\-\ simple\\:\\ 0\\.003333609056198263\ \(0\)\
\-\ somewhat\\:\\ 0\\.003325730726148249\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.003325629513272869\ \(0\)\
\-\ uncommon\\:\\ 0\\.0033102054123015537\ \(0\)\
\-\ hr\\:\\ 0\\.0032949786807672013\ \(0\)\
\-\ appreciated\\:\\ 0\\.0032949786807672013\ \(0\)\
\-\ spread\\:\\ 0\\.003272673948410355\ \(0\)\
\-\ larger\\:\\ 0\\.003258145730937515\ \(0\)\
\-\ followup\\:\\ 0\\.003229865380500398\ \(0\)\
\-\ unlikely\\:\\ 0\\.0032229503528133398\ \(0\)\
\-\ 1\\:\\ 0\\.0032198358954231305\ \(0\)\
\-\ nature\\:\\ 0\\.003202560411322908\ \(0\)\
\-\ therefore\\:\\ 0\\.0031958788051108223\ \(0\)\
\-\ involve\\:\\ 0\\.0031892531125767634\ \(0\)\
\-\ states\\:\\ 0\\.003182682405676767\ \(0\)\
\-\ repeat\\:\\ 0\\.003182682405676767\ \(0\)\
\-\ steroids\\:\\ 0\\.003182682405676767\ \(0\)\
\-\ imaging\\:\\ 0\\.003170346515369125\ \(0\)\
\-\ work\\:\\ 0\\.003169702350430784\ \(0\)\
\-\ involves\\:\\ 0\\.0031443636876547164\ \(0\)\
\-\ though\\:\\ 0\\.0031381537292532705\ \(0\)\
\-\ of\\:\\ 0\\.0031362860072300922\ \(0\)\
\-\ unable\\:\\ 0\\.0031258780471186977\ \(0\)\
\-\ sudden\\:\\ 0\\.0031258780471186977\ \(0\)\
\-\ rest\\:\\ 0\\.003119810847795207\ \(0\)\
\-\ displaced\\:\\ 0\\.003107814169235744\ \(0\)\
\-\ discharged\\:\\ 0\\.0031018833127597675\ \(0\)\
\-\ off\\:\\ 0\\.003090153236920385\ \(0\)\
\-\ lack\\:\\ 0\\.0030785944091918397\ \(0\)\
\-\ were\\:\\ 0\\.003072504096104388\ \(0\)\
\-\ subsequently\\:\\ 0\\.003067201901312109\ \(0\)\
\-\ lower\\:\\ 0\\.0030433286925793546\ \(0\)\
\-\ cbc\\:\\ 0\\.00302320360269389\ \(0\)\
\-\ there\\:\\ 0\\.003020702034358643\ \(0\)\
\-\ circumscribed\\:\\ 0\\.0030073147958444763\ \(0\)\
\-\ surface\\:\\ 0\\.0029866138614784254\ \(0\)\
\-\ large\\:\\ 0\\.0029588953789882497\ \(0\)\
\-\ count\\:\\ 0\\.0029419255709756923\ \(0\)\
\-\ bp\\:\\ 0\\.002937112391184416\ \(0\)\
\-\ round\\:\\ 0\\.002922845957690609\ \(0\)\
\-\ had\\:\\ 0\\.0029197938546962916\ \(0\)\
\-\ resolution\\:\\ 0\\.002918147038039133\ \(0\)\
\-\ 2\\:\\ 0\\.0029138630190190754\ \(0\)\
\-\ suspected\\:\\ 0\\.0029134758407887854\ \(0\)\
\-\ displacement\\:\\ 0\\.0028996253598327147\ \(0\)\
\-\ suggestive\\:\\ 0\\.00289052450518051\ \(0\)\
\-\ for\\:\\ 0\\.002886413890113678\ \(0\)\
\-\ suggest\\:\\ 0\\.002881527071569809\ \(0\)\
\-\ arm\\:\\ 0\\.0028337897554525327\ \(0\)\
\-\ condition\\:\\ 0\\.0028295893973926014\ \(0\)\
\-\ mass\\:\\ 0\\.002822947759970462\ \(0\)\
\-\ references\\:\\ 0\\.0028130073120044437\ \(0\)\
\-\ i\\:\\ 0\\.002796765396063745\ \(0\)\
\-\ same\\:\\ 0\\.0027887676953618416\ \(0\)\
\-\ prominent\\:\\ 0\\.0027769206069400577\ \(0\)\
\-\ pathology\\:\\ 0\\.0027691198971672853\ \(0\)\
\-\ initially\\:\\ 0\\.002753745324042106\ \(0\)\
\-\ tender\\:\\ 0\\.0027461685615590096\ \(0\)\
\-\ considered\\:\\ 0\\.002731229144057519\ \(0\)\
\-\ reports\\:\\ 0\\.002727537922279363\ \(0\)\
\-\ vessels\\:\\ 0\\.002723863829202164\ \(0\)\
\-\ cells\\:\\ 0\\.002712942750712587\ \(0\)\
\-\ solid\\:\\ 0\\.00269861175970418\ \(0\)\
\-\ symptomatic\\:\\ 0\\.0026880312151181408\ \(0\)\
\-\ vs\\:\\ 0\\.002663879628187488\ \(0\)\
\-\ pressure\\:\\ 0\\.002657112359320934\ \(0\)\
\-\ change\\:\\ 0\\.002637150823813019\ \(0\)\
\-\ midline\\:\\ 0\\.0026176801958341417\ \(0\)\
\-\ malignancy\\:\\ 0\\.0026144811384018335\ \(0\)\
\-\ \\<\\:\\ 0\\.0026112949544748933\ \(0\)\
\-\ note\\:\\ 0\\.0026112949544748933\ \(0\)\
\-\ process\\:\\ 0\\.002604960795593598\ \(0\)\
\-\ er\\:\\ 0\\.0025955535684465255\ \(0\)\
\-\ classic\\:\\ 0\\.0025924425010356864\ \(0\)\
\-\ commonly\\:\\ 0\\.0025530731935515766\ \(0\)\
\-\ confirmed\\:\\ 0\\.0025442593848668225\ \(0\)\
\-\ \\â\\€\\œ\\:\\ 0\\.0025269207583366268\ \(0\)\
\-\ \\â\\€\\\\:\\ 0\\.0025127564156994333\ \(0\)\
\-\ clear\\:\\ 0\\.002501604602649759\ \(0\)\
\-\ breast\\:\\ 0\\.002496087049747072\ \(0\)\
\-\ since\\:\\ 0\\.002485165971257495\ \(0\)\
\-\ very\\:\\ 0\\.0024558872671869587\ \(0\)\
\-\ portion\\:\\ 0\\.0024506782639422695\ \(0\)\
\-\ they\\:\\ 0\\.0024378037422702345\ \(0\)\
\-\ weight\\:\\ 0\\.0024251352218059106\ \(0\)\
\-\ would\\:\\ 0\\.002407733078718994\ \(0\)\
\-\ palpable\\:\\ 0\\.0023979580701502697\ \(0\)\
\-\ effect\\:\\ 0\\.0023955330586454826\ \(0\)\
\-\ typically\\:\\ 0\\.002388302271976225\ \(0\)\
\-\ or\\:\\ 0\\.002378913893025434\ \(0\)\
\-\ inflammatory\\:\\ 0\\.0023462517372858462\ \(0\)\
\-\ 3\\.\\:\\ 0\\.002315023129169222\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0023041619761772986\ \(0\)\
\-\ elevated\\:\\ 0\\.002295579066792607\ \(0\)\
\-\ masses\\:\\ 0\\.0022870882011053737\ \(0\)\
\-\ although\\:\\ 0\\.002284979636244342\ \(0\)\
\-\ three\\:\\ 0\\.00228077927818441\ \(0\)\
\-\ possible\\:\\ 0\\.002278687425878125\ \(0\)\
\-\ size\\:\\ 0\\.0022683102702919806\ \(0\)\
\-\ palpation\\:\\ 0\\.002258067363696003\ \(0\)\
\-\ flow\\:\\ 0\\.0022359888177818812\ \(0\)\
\-\ surrounding\\:\\ 0\\.002224200526021192\ \(0\)\
\-\ cancer\\:\\ 0\\.002224200526021192\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0022222527620933516\ \(0\)\
\-\ showed\\:\\ 0\\.0022183715502167036\ \(0\)\
\-\ disease\\:\\ 0\\.002211777579122255\ \(0\)\
\-\ should\\:\\ 0\\.002156934712501029\ \(0\)\
\-\ further\\:\\ 0\\.00215157889295349\ \(0\)\
\-\ 2\\.\\:\\ 0\\.00215157889295349\ \(0\)\
\-\ past\\:\\ 0\\.002149801640495989\ \(0\)\
\-\ differential\\:\\ 0\\.0021480283684504587\ \(0\)\
\-\ day\\:\\ 0\\.0021480283684504587\ \(0\)\
\-\ between\\:\\ 0\\.0021444936945560125\ \(0\)\
\-\ right\\:\\ 0\\.002141643014514054\ \(0\)\
\-\ adjacent\\:\\ 0\\.0021392210959099503\ \(0\)\
\-\ area\\:\\ 0\\.0021392210959099503\ \(0\)\
\-\ onset\\:\\ 0\\.0021357254362036025\ \(0\)\
\-\ 1\\.\\:\\ 0\\.00211337226151829\ \(0\)\
\-\ examination\\:\\ 0\\.0021032644778104237\ \(0\)\
\-\ clinical\\:\\ 0\\.002081797149695965\ \(0\)\
\-\ days\\:\\ 0\\.0020736930294314943\ \(0\)\
\-\ fat\\:\\ 0\\.002057729471798601\ \(0\)\
\-\ yo\\:\\ 0\\.0020359077777535725\ \(0\)\
\-\ negative\\:\\ 0\\.0020206810462192193\ \(0\)\
\-\ from\\:\\ 0\\.00200544055923074\ \(0\)\
\-\ lung\\:\\ 0\\.001959745938431311\ \(0\)\
\-\ when\\:\\ 0\\.0019377127772098224\ \(0\)\
\-\ two\\:\\ 0\\.0019377127772098224\ \(0\)\
\-\ syndrome\\:\\ 0\\.0019350012484043084\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0019175991053173923\ \(0\)\
\-\ region\\:\\ 0\\.0019110065140453781\ \(0\)\
\-\ likely\\:\\ 0\\.0019083847711287858\ \(0\)\
\-\ chronic\\:\\ 0\\.0019057716808448138\ \(0\)\
\-\ include\\:\\ 0\\.001897983759327226\ \(0\)\
\-\ secondary\\:\\ 0\\.0018915518341320724\ \(0\)\
\-\ 4\\:\\ 0\\.0018851717380673357\ \(0\)\
\-\ blood\\:\\ 0\\.0018467229394372917\ \(0\)\
\-\ presented\\:\\ 0\\.0018443053325593105\ \(0\)\
\-\ if\\:\\ 0\\.0018359013727479298\ \(0\)\
\-\ at\\:\\ 0\\.0018333541612535755\ \(0\)\
\-\ cell\\:\\ 0\\.0018275856782117863\ \(0\)\
\-\ \\.\\:\\ 0\\.0018269753335926429\ \(0\)\
\-\ cyst\\:\\ 0\\.0018181877561568506\ \(0\)\
\-\ both\\:\\ 0\\.0017277909664973248\ \(0\)\
\-\ metastatic\\:\\ 0\\.0017031745080095726\ \(0\)\
\-\ abdominal\\:\\ 0\\.0016911474569454594\ \(0\)\
\-\ symptoms\\:\\ 0\\.0016861896095788907\ \(0\)\
\-\ physical\\:\\ 0\\.001659940831022358\ \(0\)\
\-\ increased\\:\\ 0\\.0016551740156766869\ \(0\)\
\-\ soft\\:\\ 0\\.0016476063056164291\ \(0\)\
\-\ noted\\:\\ 0\\.0016036588982205808\ \(0\)\
\-\ tissue\\:\\ 0\\.0016036588982205808\ \(0\)\
\-\ 3\\:\\ 0\\.0015843036632672523\ \(0\)\
\-\ woman\\:\\ 0\\.0015628685253277167\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0015569692330427874\ \(0\)\
\-\ may\\:\\ 0\\.0014840287956438035\ \(0\)\
\-\ findings\\:\\ 0\\.0014400925857402688\ \(0\)\
\-\ images\\:\\ 0\\.0012979128202291006\ \(0\)\
\-\ within\\:\\ 0\\.0012906820335598429\ \(0\)\
\-\ which\\:\\ 0\\.0012629806708175364\ \(0\)\
\-\ with\\:\\ 0\\.0009263988605691981\ \(0\)\
\-\ left\\:\\ 0\\.0007570112979199641\ \(0\)\
\-\ no\\:\\ 0\\.0006812701114044355\ \(0\)\
